AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy

Wei Zhanga,1, Yibao Fana,b,1, Milad Ashrafizadeha, Dan Shia, Gautam Sethic, Yavuz Nuri Ertasd,e, A.M. Abd El-Atyf,g, Xianbin Zhanga, Si Chenh( ), Peng Gonga( )
Department of General Surgery, Institute of Precision Diagnosis and Treatment of Digestive System Tumors and Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong 518055, China
School of Pharmacy, Shenzhen University Medical School, Shenzhen, Guangdong 518060, China
Department of Pharmacology and NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore
Department of Biomedical Engineering, Erciyes University, Kayseri 38039, Turkey
Department of Technical Sciences, Western Caspian University, AZ1001, Baku, Azerbaijan
Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum 25240, Turkey
Department of Immunology, Shenzhen University Medical School, Shenzhen, Guangdong 518060, China

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

1 Wei Zhang and Yibao Fan contributed equally.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 3,
May 2025
Article number: 101503
DOI: 10.1016/j.gendis.2024.101503

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Zhang W, Fan Y, Ashrafizadeh M, et al. A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy. Genes & Diseases, 2025, 12(3): 101503. https://doi.org/10.1016/j.gendis.2024.101503

240

Views

1

Downloads

2

Crossref

3

Web of Science

3

Scopus

0

CSCD
Received: 21 December 2023
Published: 24 December 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).